Trial intelligence / Profile preview

DRIVE: IV Iron in Dialysis Patients with Elevated Ferritin

NCT00224081Phase 4Completed

Sponsor
Watson Pharmaceuticals
Start
Sep 2004
Primary completion
May 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sodium ferric gluconate in iron deficiency anemia (IDA), sponsored by Watson Pharmaceuticals. Started Sep 2004; status: completed.

02

Drugs

sodium ferric gluconate
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT00224081.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00224081.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call